The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
QuANTUM-Wild: A phase 3, randomized, double-blind, placebo-controlled trial of quizartinib in combination with chemotherapy and as single-agent maintenance in FLT3-ITD–negative acute myeloid leukemia (AML).
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Jazz Pharmaceuticals; Otsuka; Pfizer; SERVIER
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Abbvie (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen-Cilag (Inst); Pfizer (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen
 
June-Won Cheong
No Relationships to Disclose
 
Naval Daver
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; Immunogen; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; SERVIER; Shattuck Labs; Stemline/Menarini; Syndax; Trillium Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); FATE Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immunogen (Inst); Kite, a Gilead company (Inst); Novimmune (Inst); Pfizer (Inst); Servier (Inst); Trillium Therapeutics (Inst); Trovagene (Inst)
 
Amir Fathi
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Genentech; Ipsen; Kite/Gilead; Menarini Group; Orum Therapeutics; Pfizer; Remix Therapeutics; Rigel; SERVIER; Takeda
Research Funding - Abbvie; Bristol-Myers Squibb; SERVIER
 
Mark Levis
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo; Sumitomo Dainippon Pharma Oncology; Syndax; Takeda
Research Funding - Astellas Pharma (Inst)
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Astellas Pharma
 
Selina Luger
Honoraria - Abbvie/Genentech; Amgen
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Daichi Sankyo; Daiichi Sankyo/UCB Japan; Marker Therapeutics; Novartis
Research Funding - Celgene (Inst); Onconova Therapeutics (Inst); Takeda
Travel, Accommodations, Expenses - Amgen
 
Toshihiro Miyamoto
Honoraria - Astellas Pharma; Janssen; Kyowa Kirin Pharmaceutical Development; Otsuka; Takeda
Research Funding - Chugai Pharma; Kyowa Kirin Pharmaceutical Development
 
Esther Oliva
Honoraria - Alexion Pharmaceuticals; Amgen; Celgene/Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Novartis; Sobi
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Daiichi Sankyo
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Royalties for QOL-E instrument
 
Alexander Perl
Honoraria - Astellas Pharma; Daiichi Sankyo
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Curis; Daiichi Sankyo; Foghorn Therapeutics; Genentech; Rigel; Schrodinger; Syndax
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Daiichi Sankyo (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Daiichi Sankyo
 
Christian Recher
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Jazz Pharmaceuticals; Johnson & Johnson; SERVIER
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol Myers Squibb Foundation (Inst); IQVIA (Inst); Jazz Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AbbVie; Novartis; SERVIER
 
Richard Schlenk
Honoraria - Daiichi Sankyo; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; BerGenBio; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo
Research Funding - Abbvie; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Pfizer; PharmaMar; Recordati; Roche
Other Relationship - Abbvie; AstraZeneca; BerGenBio; Daiichi Sankyo; Pfizer; PharmaMar; Recordati
 
Jianxiang Wang
Consulting or Advisory Role - Abbvie
 
Amer Zeidan
Honoraria - Abbvie; Agios; Akeso Biopharma; ALX Oncology; Amgen; Astellas Pharma; BeiGene; BioCryst; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chiesi; Daiichi Sankyo; Epizyme; Faron Pharmaceuticals; Genentech; Geron; Gilead Sciences; Glycomimetics; Hikma Pharmaceuticals; Janssen; Karyopharm Therapeutics; Keros Therapeutics; Kura Oncology; Kyowa Kirin International; lava therapeutics; Mendus; Notable Labs; Novartis; Orum Therapeutics; Otsuka; Pfizer; Regeneron; Rigel; Schrodinger; SERVIER; Shattuck Labs; Sumitomo Pharma Oncology; Syndax; Syros Pharmaceuticals; Taiho Pharmaceutical; Takeda; Treadwell Therapeutics; Vincerx Pharma; Zentalis
Consulting or Advisory Role - Abbvie; Agios; Akeso Biopharma; ALX Oncology; Amgen; Astellas Pharma; Astex Pharmaceuticals; BeiGene; BioCryst; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chiesi; Daiichi Sankyo; Epizyme; Faron Pharmaceuticals; Genentech; Geron; Gilead Sciences; Glycomimetics; Hikma Pharmaceuticals; Janssen; Karyopharm Therapeutics; Keros Therapeutics; Kura Oncology; Kyowa Kirin International; lava therapeutics; Mendus; Notable Labs; Novartis; Orum Therapeutics; Otsuka; Pfizer; Regeneron; Rigel; Schrodinger; SERVIER; Shattuck Labs; Sumitomo Pharma Oncology; Syndax; Syros Pharmaceuticals; Taiho Pharmaceutical; Takeda; Treadwell Therapeutics; Vincerx Pharma; Zentalis
Research Funding - Abbvie (Inst); Amgen; Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Geron; Kura Oncology; Novartis (Inst); Otsuka; Shattuck Labs; Syros Pharmaceuticals; Takeda (Inst)
 
Li Liu
Employment - Daiichi Sankyo
 
Yvonne Duong
Employment - Daiichi Sankyo
 
Karima Imadalou
Employment - Daiichi Sankyo
 
Karenza Alexis
Employment - Affirmed Inc; Daiichi Sankyo
 
Akash Nahar
Employment - Daiichi Sankyo
 
Kristy Burns
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Harry Erba
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb/Celgene; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Janssen Oncology; Jazz Pharmaceuticals; Kura Oncology; Macrogenics; Novartis; Pfizer; Schrodinger; SERVIER; Stemline Therapeutics; Sumitomo Dainippon Pharma Oncology; Takeda; Trillium Therapeutics
Speakers' Bureau - Abbvie; Agios; Bristol Myers Squibb Foundation; Incyte; Jazz Pharmaceuticals; Novartis; SERVIER; Syndax
Research Funding - Abbvie (Inst); Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Aptose Biosciences (Inst); Ascentage Pharma (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); Glycomimetics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Macrogenics (Inst); Novartis (Inst); Oryzon Genomics (Inst); PTC Therapeutics (Inst); SERVIER (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Taiho Oncology (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo